Sequence-Selective Decapeptide Synthesis by the Parallel Operation of Two Artificial Molecular Machines

We report on the preparation of a decapeptide through the parallel operation of two rotaxane-based molecular machines. The synthesis proceeds in four stages: (1) simultaneous operation of two molecular peptide synthesizers in the same reaction vessel; (2) selective residue activation of short-oligomer intermediates; (3) ligation; (4) product release. Key features of the machine design include the following: (a) selective transformation of a thioproline building block to a cysteine (once it has been incorporated into a hexapeptide intermediate by one molecular machine); (b) a macrocycle-peptide hydrazine linkage (as part of the second machine) to differentiate the intermediates and enable their directional ligation; and (c) incorporation of a Glu residue in the assembly module of one machine to enable release of the final product while simultaneously removing part of the assembly machinery from the product. The two molecular machines participate in the synthesis of a product that is beyond the capability of individual small-molecule machines, in a manner reminiscent of the ligation and post-translational modification of proteins in biology.

Automated summary

This study reports the preparation of a decapeptide through the parallel operation of two rotaxane-based molecular machines, involving simultaneous operation of two molecular peptide synthesizers, selective residue activation, ligation, and product release. The design of the machines enables the synthesis of a product that exceeds the capabilities of individual small-molecule machines, reminiscent of the ligation and post-translational modification of proteins in biology.